CRVS News and Press, Corvus Pharmaceuticals Inc. From 05/05/21

BURLINGAME, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that it has completed the sale of approximately $10 million of its common shares pursuant to the Company’s ATM program establis...

Corvus Pharmaceuticals (CRVS): Q1 GAAP EPS of -$0.34 misses by $0.04.Cash, cash equivalents and marketable securities of $68.0MPress Release For further details see: Corvus Pharmaceuticals EPS misses by $0.04

BURLINGAME, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the first quarter ended March 31, 2021. “In the first quarter we i...

Corvus Pharmaceuticals (CRVS): Q4 GAAP EPS of $0.92 beats by $1.16.Cash, cash equivalents and marketable securities of $44.3MPress Release For further details see: Corvus Pharmaceuticals EPS beats by $1.16

BURLINGAME, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2020. “In 2020, we ...

The following slide deck was published by Corvus Pharmaceuticals, Inc. in conjunction with this event. For further details see: Corvus Pharmaceuticals (CRVS) Investor Presentation - Slideshow

BURLINGAME, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the Company’s management will participate in two upcoming investor conferences in March: The first conference w...

Institutions & Insiders Are Buying These Penny Stocks Right Now If there’s one thing that gets traders excited about penny stocks , it’s when “big buyers” are present. But how would you know a major institution was buying shares of a company? Furtherm...

Are Analysts Right About These Penny Stocks To Buy? Who’s ready for another busy week with penny stocks ? I know after a short week last week – and a volatile one at that – many are anticipating what to expect this week. Surely we’ll see continued attenti...

Gainers: [[RNWK]] +14.1%. [[VIOT]] +8%. [[IMUX]] +7.5%. [[CRVS]] +6.4%. [[OTIC]] +4.4%.Losers: [[PT]] -4.7%. [[OBSV]] -2.8%. [[PETS]] -2.6%. [[EVGN]] -2%. [[EOLS]] -1.7%. For further details see: PETS, IMUX, EVGN and OTIC among after-hours movers